More recently, given that cancer progression is preceded by a long period of subclinical inflammation [20-22], the genetic polymorphisms of TNF-α, TNFRSF1A and TNFRSF1B have been examined in terms of susceptibility to various cancers [23-28]. This evidence concerns the gene TNFRSF1B and cancer.